Description

PROLOMET XL 25 MG (1X15)

Indications

PROLOMET XL 25 MG is primarily indicated for the management of hypertension (high blood pressure) and for the treatment of angina pectoris (chest pain due to reduced blood flow to the heart). It may also be prescribed for the prevention of myocardial infarction (heart attack) in patients with a history of coronary artery disease. Additionally, this medication can be used to improve exercise tolerance in patients with chronic stable angina.

Mechanism of Action

PROLOMET XL contains the active ingredient Metoprolol, which is a selective beta-1 adrenergic receptor blocker. By blocking these receptors, Metoprolol decreases heart rate, myocardial contractility, and conduction velocity through the atrioventricular (AV) node. This results in a reduction in cardiac output and overall workload on the heart, thereby lowering blood pressure and alleviating angina symptoms. The extended-release formulation allows for sustained therapeutic effects over a 24-hour period, enhancing patient compliance.

Pharmacological Properties

Metoprolol is well-absorbed following oral administration, with peak plasma concentrations typically occurring within 1 to 2 hours. The drug undergoes extensive first-pass metabolism in the liver, leading to a bioavailability of approximately 50%. The half-life of Metoprolol is about 3 to 7 hours, but the extended-release formulation of PROLOMET XL allows for once-daily dosing. Metoprolol is primarily eliminated through hepatic metabolism, with renal excretion accounting for a minor portion of the drug’s elimination pathway.

Contraindications

PROLOMET XL is contraindicated in patients with known hypersensitivity to Metoprolol or any of its components. It should not be used in individuals with severe bradycardia (slow heart rate), heart block greater than first degree, cardiogenic shock, or overt heart failure. Additionally, caution is advised in patients with asthma or other chronic obstructive pulmonary diseases, as beta-blockers can potentially induce bronchospasm.

Side Effects

Common side effects associated with PROLOMET XL include fatigue, dizziness, depression, and gastrointestinal disturbances such as nausea and diarrhea. Other potential side effects may include bradycardia, hypotension, and peripheral edema. In rare cases, patients may experience more severe adverse reactions, including exacerbation of heart failure, severe allergic reactions, or signs of liver dysfunction. Patients should be advised to report any unusual symptoms to their healthcare provider promptly.

Dosage and Administration

The recommended starting dose of PROLOMET XL for hypertension is typically 25 mg once daily, which may be adjusted based on individual patient response and tolerance. For angina, the initial dose may also be 25 mg once daily, with titration as necessary. It is important to swallow the tablet whole, without chewing or crushing, to maintain the extended-release properties. Patients should adhere to their prescribed regimen and consult their healthcare provider before making any changes to their dosage.

Interactions

PROLOMET XL may interact with a variety of medications, which can either potentiate or diminish its effects. Co-administration with other antihypertensive agents may lead to additive hypotensive effects. Caution is advised when using Metoprolol with drugs that affect hepatic metabolism, such as certain antifungal agents (e.g., ketoconazole) and antidepressants (e.g., fluoxetine). Additionally, the use of non-steroidal anti-inflammatory drugs (NSAIDs) may reduce the antihypertensive effect of Metoprolol. Patients should inform their healthcare provider of all medications they are taking to avoid potential interactions.

Precautions

Before initiating treatment with PROLOMET XL, a thorough medical history should be obtained, and patients should be assessed for any pre-existing conditions that may contraindicate its use. Special caution should be exercised in patients with a history of heart failure, diabetes mellitus, or those undergoing surgery, as beta-blockers can mask hypoglycemic symptoms. Gradual withdrawal of the medication is recommended to avoid rebound hypertension or exacerbation of angina symptoms. Regular monitoring of blood pressure and heart rate is essential during treatment.

Clinical Studies

Clinical studies have demonstrated the efficacy of Metoprolol in reducing blood pressure and improving symptoms of angina. In a randomized controlled trial involving patients with hypertension, Metoprolol was shown to significantly lower systolic and diastolic blood pressure compared to placebo. Another study highlighted its effectiveness in improving exercise capacity in patients with stable angina. Long-term data supports the use of Metoprolol in reducing cardiovascular morbidity and mortality in patients with coronary artery disease.

Conclusion

PROLOMET XL 25 MG is an effective medication for managing hypertension and angina pectoris, offering the benefits of once-daily dosing due to its extended-release formulation. Understanding its mechanism of action, pharmacological properties, and potential side effects is crucial for healthcare providers and patients alike. Proper usage and adherence to prescribed dosages can lead to significant improvements in cardiovascular health and overall quality of life.